Loading
BioCorRx Inc. Stock: price and insider trades · United States
US·Mcap US$7.6M
BioCorRx Inc.: what insiders have been doing
Insider filings for BioCorRx Inc. are scarce in the SEC (Form 4) feed, the latest one published on 3 October 2023. This page will fill in as new trades are disclosed. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
5
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
as of FY 2025FY ended December 2025 · cache
US$0.26
Analyst consensus
Income statement
RevenueUS$797.2k
Gross profitUS$775.4k97% margin
EBITDA-US$2.6M-322% margin
Net income-US$3.4M-431.5% margin
Valuation
Beta0.18
Balance sheet & cash
Market capUS$7.6M
Total debtUS$2.1M
Free Cash Flow-US$2.3M
Profitability & ownership
ROA-66.3%
% insiders61.4%
% institutions0.0%
Last declaration on 3 October 2023
Declarations5 total
2,858 shares0Common Stock, par value $0.001SEC:0001477932-23-007312:0
2,858 shares0Common Stock, par value $0.001SEC:0001477932-23-007294:0
2,858 shares0Common Stock, par value $0.001SEC:0001477932-23-007297:0
2,858 shares0Common Stock, par value $0.001SEC:0001477932-23-007296:0
2,858 shares0Common Stock, par value $0.001SEC:0001477932-23-007298:0
5 of 5 declarations
About BioCorRx Inc.
BioCorRx Inc. is a company focused on developing treatments for addiction-related disorders. It aims to provide innovative solutions to help individuals overcome their dependencies.
